Médica Sur S.A.B. de C.V (MX:MEDICAB) — Market Cap & Net Worth
Market Cap & Net Worth: Médica Sur S.A.B. de C.V (MEDICAB)
Médica Sur S.A.B. de C.V (MX:MEDICAB) has a market capitalization of $312.73 Million (MX$5.43 Billion) as of August 1, 2026. Listed on the MX stock exchange, this Mexico-based company holds position #14369 globally and #107 in its home market, demonstrating a 0.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Médica Sur S.A.B. de C.V's stock price MX$59.50 by its total outstanding shares 91327317 (91.33 Million). See Médica Sur S.A.B. de C.V (MEDICAB) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Médica Sur S.A.B. de C.V Market Cap History: 2015 to 2026
Médica Sur S.A.B. de C.V's market capitalization history from 2015 to 2026. Data shows growth from $96.79 Million to $312.73 Million (10.17% CAGR).
Médica Sur S.A.B. de C.V Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Médica Sur S.A.B. de C.V's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.07x
Médica Sur S.A.B. de C.V's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.58x
Médica Sur S.A.B. de C.V's market cap is 0.58 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $95.75 Million | $2.59 Billion | $142.63 Million | 0.04x | 0.67x |
| 2017 | $94.35 Million | $3.43 Billion | $231.80 Million | 0.03x | 0.41x |
| 2018 | $79.64 Million | $3.61 Billion | $169.30 Million | 0.02x | 0.47x |
| 2019 | $50.34 Million | $3.70 Billion | $140.55 Million | 0.01x | 0.36x |
| 2020 | $78.70 Million | $4.47 Billion | $558.83 Million | 0.02x | 0.14x |
| 2021 | $119.50 Million | $3.91 Billion | $1.15 Billion | 0.03x | 0.10x |
| 2022 | $160.71 Million | $3.87 Billion | $949.80 Million | 0.04x | 0.17x |
| 2023 | $205.56 Million | $4.13 Billion | $634.98 Million | 0.05x | 0.32x |
| 2024 | $178.70 Million | $4.40 Billion | $461.51 Million | 0.04x | 0.39x |
| 2025 | $315.35 Million | $4.79 Billion | $540.25 Million | 0.07x | 0.58x |
Competitor Companies of MEDICAB by Market Capitalization
Companies near Médica Sur S.A.B. de C.V in the global market cap rankings as of August 1, 2026.
Key companies related to Médica Sur S.A.B. de C.V by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #324 globally with a market cap of $80.16 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #902 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1346 globally with a market cap of $18.52 Billion USD ( RM73.78 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #324 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $395.79 |
| #902 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €44.88 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1346 | IHH Healthcare Bhd | KLSE:5225 | $18.52 Billion | RM8.35 |
Médica Sur S.A.B. de C.V Historical Marketcap From 2015 to 2026
Between 2015 and today, Médica Sur S.A.B. de C.V's market cap moved from $96.79 Million to $ 312.73 Million, with a yearly change of 10.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | MX$312.73 Million | -0.83% |
| 2025 | MX$315.35 Million | +76.47% |
| 2024 | MX$178.70 Million | -13.07% |
| 2023 | MX$205.56 Million | +27.91% |
| 2022 | MX$160.71 Million | +34.49% |
| 2021 | MX$119.50 Million | +51.84% |
| 2020 | MX$78.70 Million | +56.35% |
| 2019 | MX$50.34 Million | -36.79% |
| 2018 | MX$79.64 Million | -15.59% |
| 2017 | MX$94.35 Million | -1.46% |
| 2016 | MX$95.75 Million | -1.08% |
| 2015 | MX$96.79 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 31st, 2026 the market cap of Médica Sur S.A.B. de C.V was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $312.73 Million USD |
| MoneyControl | $312.73 Million USD |
| MarketWatch | $312.73 Million USD |
| marketcap.company | $312.73 Million USD |
| Reuters | $312.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Médica Sur S.A.B. de C.V
Médica Sur, S.A.B. de C.V. operates as a healthcare hospital in Mexico. The company offers angiology, vascular, and endovascular surgery; bariatric surgery; cancer; cardiology; checkup and preventive medicine; children; dental; emergency; endocrinology; gastroenterology, hepatology, and endoscopy; general surgery; geriatric; and gynecology and obstetrics services. It also provides specialized sur… Read more